New CEO and Key Board of Directors Appointments Join Co-Founders and Preeminent HDAC Scientists from Dana-Farber and Harvard University to Lead Development of Highly Selective HDAC Therapeutics CAMBRIDGE, Mass., Aug 7–(HSMN NewsFeed)–Acetylon Pharmace…
Biopharmaceuticals, Venture Capital, Personnel
Acetylon Pharmaceuticals
Posts on ‘August 7th, 2009’
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis
Merck Shareholders Approve Merger With Schering-Plough
WHITEHOUSE STATION, N.J.–(HSMN NewsFeed)–Merck & Co. (NYSE: MRK ) today announced that its shareholders voted overwhelmingly to approve the proposed merger with Schering-Plough (NYSE: SGP ). The preliminary tabulation indicates that more than 99% of shar…
Biopharmaceuticals, Mergers & Acquisitions
Merck, Schering-Plough

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.